Here's a quick look at the stocks that will be in focus in trade on Monday, covering quarterly earnings, order wins, and USFDA approvals announced by companies over the weekend:
HDFC Asset Management Company, HDFC Life Insurance Company, Jio Financial Services, Bank of Maharashtra, Angel One, SpiceJet, Den Networks, Hatsun Agro Product, Atam Valves, Benares Hotels, Davangere Sugar Company, Ganesh Housing Corporation, Jiya Eco-Products, Kellton Tech Solutions, Modern Engineering and Projects, Monarch Networth Capital, MRP Agro, Scanpoint Geomatics, and Udaipur Cement Works will release quarterly earnings on July 15.
HCL Technologies Q1 (Consolidated QoQ)
Net profit rises 6.8% to Rs 4,257 crore Vs Rs 3,986 crore
Revenue drops 1.6% to Rs 28,057 crore Vs Rs 28,499 crore
EBIT declines 4.4% to Rs 4,795 crore Vs Rs 5,018 crore
Margin slips to 17.1% Vs 17.6%
Dollar revenue falls 1.9% to $3,364 million Vs $3,430 million
Constant currency revenue down 1.6%
Forecast FY25 revenue growth at 3-5% YoY in constant currency
Sees FY25 EBIT margin at 18-19%
Declares an interim dividend of Rs 12 per share
Avenue Supermarts (DMart) Q1 (Consolidated YoY)
Net profit grows 17.5% to Rs 774 crore Vs Rs 659 crore
Revenue jumps 18.6% to Rs 14,069 crore Vs Rs 11,865 crore
EBITDA surges 18% to Rs 1,221 crore Vs Rs 1,035 crore
Margin flat at 8.7%
Indian Renewable Energy Development Agency (IREDA) Q1 (YoY)
Net profit spikes 30.2% to Rs 383.7 crore Vs Rs 294.6 crore
Net interest income surges 37.6% to Rs 507.8 crore Vs Rs 369 crore
5paisa Capital Q1 (Consolidated YoY)
Net profit jumps 39% to Rs 20.1 crore Vs Rs 14.5 crore
Revenue grows 21% to Rs 102.3 crore Vs Rs 84.6 crore
Bhansali Engineering Polymers Q1 (Consolidated YoY)
Net profit increases 5.6% to Rs 53.4 crore Vs Rs 50.5 crore
Revenue climbs 15.5% to Rs 340 crore Vs Rs 294.5 crore
EBITDA rises 8.9% to Rs 61.6 crore Vs Rs 56.6 crore
Margin drops to 18.1% Vs 19.2%
Plastiblends India Q1 (YoY)
Net profit spikes 41.8% to Rs 10.8 crore Vs Rs 7.6 crore
Revenue grows 8.1% to Rs 211.6 crore Vs Rs 195.7 crore
EBITDA zooms 24.3% to Rs 16.3 crore Vs Rs 13.1 crore
Margin expands to 7.7% Vs 6.7%
Geojit Financial Services Q1 (Consolidated YoY)
Net profit surges 107.5% to Rs 45.81 crore Vs Rs 22.1 crore
Revenue jumps 56.2% to Rs 181.2 crore Vs Rs 116 crore
Stocks To Watch
The global pharmaceutical company has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its manufacturing facility in Dabhasa, Gujarat. The EIR was issued following the last inspection of the facility conducted from April 8 to April 12, 2024. The inspection concluded with no observations, and the facility received an inspection classification of “No Action Indicated” (NAI).
The US FDA conducted a Pre-Approval Inspection (PAI) of the company's PPDS Ahmedabad facility from July 10 to July 12. The inspection was completed with zero Form 483 observations and a designation of "No Action Indicated" (NAI).
According to the annual report, the FMCG major aims to achieve double-digit revenue growth in the medium term and expects domestic revenue growth to outpace volume growth from Q1FY25.
The company has received a Letter of Acceptance from Central Railway for a project worth Rs 132.6 crore. The project involves OHE modification work to upgrade the existing 1 x 25 kV electric traction system to a 2 x 25 kV AT Feeding System in the Wardha-Ballarshah section of Nagpur division, Central Railway, to meet a 3000 MT loading target.
The company completed its qualified institutional placement (QIP), raising Rs 800 crore. The QIP received total demand of Rs 2,800 crore, which was 3.5 times the size of the QIP.
The company has received tentative approval from the US Food & Drug Administration (USFDA) for Selexipag for injection, 1,800 mcg/vial. Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension.
The company has received a Make II project from the Indian Army. This project involves the procurement of a Vehicle Mounted Counter Swarm Drone System (VMCSDS) (Version I) under the Make II category of DAP-2020.
The United States Food & Drug Administration (US FDA) has completed the surveillance inspection of Casper Pharma in Hyderabad, the wholly-owned subsidiary of the company. The inspection was conducted from July 8 to 12. Following the inspection, the US health regulator issued a Form 483 with two procedural observations. Additionally, Suven Pharma has acquired a 51% stake in Sapala Organics.
The company has received a letter of award for the development of distribution infrastructure-loss reduction works at EDC Dehradun rural Circle of Uttarakhand from Uttarakhand Power Corporation. The order value is Rs 141.1 crore, with EMS having a 95% share and the other JV partner having the remainder.
Zomato Slovakia, the step-down subsidiary in the Slovak Republic, has been dissolved effective July 12.
R Balaji has joined the company as MD & CEO, effective July 12.
The Board of Directors will meet on July 18 to consider raising long-term bonds through a public issue or private placement of suitable tenor during the financial year 2025.
The company has entered into an agreement with Didwania Trading Company, Bhilwara, for the sale of a thermal power plant (2 X 23 MW), which has now become cost inefficient and redundant, for Rs 48.01 crore.
The bank has entered into a strategic co-lending partnership with Arka Fincap to offer MSME loans.
Bulk Deals
Oriental Carbon & Chemicals
HDFC Mutual Fund sold a 0.66% stake in the company at an average price of Rs 249.06 per share.
Stocks Turn Ex-Dividend
Alembic Pharmaceuticals, Duncan Engineering, Gujarat Themis Biosyn, India Motor Parts & Accessories, KPR Mill, NDR Auto Components, Rane Brake Lining, Siyaram Silk Mills, ZF Commercial Vehicle Control Systems India
F&O Ban
GMR Airports Infrastructure, Aditya Birla Fashion & Retail, Balrampur Chini Mills, Bandhan Bank, Chambal Fertilisers and Chemicals, GNFC, Indian Energy Exchange, India Cements, Indus Towers, Piramal Enterprises, RBL Bank
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
